Isoxazolo[3,4-d]pyridazinones positively modulate the metabotropic glutamate subtypes 2 and 4

Bioorganic & Medicinal Chemistry
Christina GatesN R Natale

Abstract

Isoxazolo[3,4-d] pyridazinones ([3,4-d]s) are selective positive modulators of the metabotropic glutamate receptors (mGluRs) subtypes 2 and 4, with no functional cross reactivity at mGluR1a, mGLuR5 or mGluR8. Modest binding for two of the [3,4-d]s is observed at the allosteric fenobam mGluR5 site, but not sufficient to translate into a functional effect. The structure activity relationship (SAR) for mGluR2 and mGluR4 are distinct: the compounds which select for mGluR2 all contain fluorine on the N-6 aryl group. Furthermore, the [3,4-d]s in this study showed no significant binding at inhibitory GABAA, nor excitatory NMDA receptors, and previously we had disclosed that they lack significant activity at the System Xc-Antiporter. A homology model based on Conn's mGluR1 crystal structure was examined, and suggested explanations for a preference for allosteric over orthosteric binding, subtype selectivity, and suggested avenues for optimization of efficacy as a reasonable working hypothesis.

References

Dec 23, 1996·Brain Research. Developmental Brain Research·L S NadlerR E Siegel
May 9, 1997·Journal of Medicinal Chemistry·V Dal PiazV Segarra
Jun 4, 1999·Journal of Medicinal Chemistry·L CostantinoD Barlocco
Jul 13, 2001·Journal of Medicinal Chemistry·D BarloccoA Leonardi
Nov 16, 2001·Journal of Medicinal Chemistry·M P GiovannoniM Canavesi
Feb 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Daisuke TsuchiyaKosuke Morikawa
Mar 21, 2002·Il Farmaco·Piaz Vittorio DalM C Castellana
Sep 6, 2002·Journal of Computational Chemistry·Alexey OnufrievDonald Bashford
Jan 18, 2003·Journal of Enzyme Inhibition and Medicinal Chemistry·Vittorio Dal PiazJosè Maria Palacios
Mar 22, 2003·The Journal of Pharmacology and Experimental Therapeutics·Qi ShiBryan L Roth
May 29, 2003·Current Drug Targets. CNS and Neurological Disorders·Jean-Philippe Pin, Francine Acher
Dec 21, 2004·Magnetic Resonance in Chemistry : MRC·V Dal PiazW Holzer
Aug 11, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Luisa IacovelliFerdinando Nicoletti
Aug 12, 2006·ChemMedChem·Edgar JacobyKlaus Seuwen
Dec 2, 2006·Nature Reviews. Drug Discovery·John P OveringtonAndrew L Hopkins
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Takanori MutoHisato Jingami
Sep 26, 2008·Journal of Chemical Information and Modeling·Jürgen KoskaC M Venkatachalam
May 16, 2009·Journal of Computational Chemistry·B R BrooksM Karplus
Nov 26, 2009·Bioorganic & Medicinal Chemistry·Sarjubhai A PatelNicholas R Natale
Feb 18, 2010·Future Medicinal Chemistry·Corey R HopkinsColleen M Niswender
Jun 29, 2010·ACS Chemical Neuroscience·Richard WilliamsCorey R Hopkins
Feb 24, 2011·Biochemistry·Michael R WoodCraig W Lindsley
Jun 22, 2011·Journal of Medicinal Chemistry·Sang-Phyo HongDarío Doller
Sep 2, 2014·Nature Reviews. Drug Discovery·P Jeffrey ConnColleen M Niswender
Oct 25, 2014·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Xavier RoviraCyril Goudet
Dec 30, 2014·Trends in Pharmacological Sciences·Vignir IsbergDavid E Gloriam
Jun 28, 2015·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Amélie S ToraCyril Goudet
Feb 21, 2016·Neuropharmacology·Lumeng J YuSuzie Chen

❮ Previous
Next ❯

Citations

Dec 5, 2020·Future Medicinal Chemistry·Oya Unsal Tan, Keriman Ozadali Sari

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.